12th Sep 2018 16:54
LONDON (Alliance News) - Life science company Arix Bioscience PLC said on Wednesday it has appointed Arthur Pappas as non-executive director.
At the same time, Non-Executive Director David U'Prichard has retired from the board with immediate effect.
Pappas was previously chairman of Nasdaq-listed CoLucid Pharmaceuticals Inc for 12 years from 2015 to 2017, and was a part of Chimerix Inc's board of directors from 2011 to 2014.
"I am very pleased to welcome Art to the Board of Arix. He brings extensive experience both as a
senior executive in the pharmaceutical industry and in building Pappas Capital as a leading life sciences venture capital firm in the United States," said Executive Chairman Jonathan Peacock.
Shares in Arix Bioscience closed flat at 174.10 pence on Wednesday.
Related Shares:
ARIX.L